Skip to main content
Sign In

University of Colorado Cancer Center

University of Colorado Cancer Center, A National Cancer Institute-designated Comprehensive Cancer Center

Yiqun Shellman, PhD



Cell Growth, Death and Senescence, Signaling Pathways, Oncogenes and Tumor Suppressor Genes, Gene Regulation and Transcription Factors, Tumor progression, invasion and metastasis, and Experimental and Molecular Therapeutics




University of Colorado Anschutz Medical Campus, Department of Dermatology


Must have completed three years of college

Number of Openings: 1

Objective:  To better understand the progression and resistance to therapy of melanoma, and thus to find better treatment strategy


  1. To examine the treatment potential of combining a small molecule inhibitor of Bcl-2 family members with conventional therapeutic agents to treat melanoma cells and melanoma-stem cells.
  2. To explore the roles of miRNAs in melanoma tumorigenesis and therapeutic potential of miRNA in melanoma treatment.